Dr. Simon Klopschinski rospatt osten pross – Intellectual Property Rechtsanwälte In the international investment arbitration of Eli Lilly v. Canada the arbitral tribunal rendered on March 16, 2017 the first final award ever on patents and international investment law, thereby creating a completely new forum for litigating patents (ICSID Case No.: UNCT/14/2). The arbitral tribunal…
The German Federal Council, the Bundesrat approved draft legislation to ratify the Unified Patent Court Agreement and to amend German patent law in its 31 March session. It means the German procedure to ratify the UPCA nears completion. The Parliament, the Bundestag, had already given its approval on 9 March 2017. In order to finalize…
Last Saturday (1 April 2017) the Spanish Official Gazette (“Boletín Oficial del Estado”) published Royal Decree 316/2017, dated 31 March, containing the Implementing Regulations of the Patents Act 24/2015, of 24 July. As readers will remember from previous blogs, the new Patents Act, which, among other aspects, introduced the compulsory examination of substantive patentability requirements,…
How long should proceedings before the EPO ideally take? Admittedly, this is a tricky question because various stakeholders will usually have different interests and thoughts as to what the “right” or “ideal” speed is. Let us tackle this question by beginning with a simple distinction. I posit that the answer depends considerably on whether the…
‘The UK will ratify the Unified Patent Court Agreement (UPCA) in March, most likely before the Brexit article 50 is triggered.’ It was only last month this scenario was described by the UPC Preparatory Committee during a conference in Amsterdam. By now, we know this has been overly optimistic, but is it a problem for the…
Spain will not join the Unitary Patent system. That became clear today during a session of the Spanish parliament. Earlier this month, the parliamentary committee for economics, industry and competitiveness had approved a motion of the socialist party PSOE, requesting the government to reconsider joining the system. Only the Popular Party, which runs the minority…
The federal district court in Wilmington, Delaware, did not abuse its discretion in finding that Bayer CropScience’s infringement suit against agrochemical rival Dow AgroSciences over soybean gene technology qualified as an “exceptional case” warranting an award of attorney fees under Section 285 of the Patent Act, the U.S. Court of Appeals for the Federal Circuit…
According to sec. 1 para 3 no. 5 Austrian Patent Act, programs for computers are not patentable per se. However a computer program may be patentable if it fulfills the technical character requirement. The Supreme Court confirmed that the technical effect is to be determined from the content of the computer program in the context…
The Dutch Government has warned the social situation at the EPO will have to improve soon. The International Labour Organisation (ILO) has complained it is not acceptable that over half of the workload of its Tribunal is generated by complaints filed against the European Patent Office. Parliaments in Germany and France have called for action…
The Federal Court of Australia has handed down its first detailed damages decision in a long time in a patent infringement claim against a generic pharmaceutical company. In doing so, it sets a new benchmark for damages claims by innovator companies whose products have been illegally copied. In Bayer Pharma Aktiengesellschaft v Generic Health Pty…
